Detalhe da pesquisa
1.
The Economic Potential of Smoking Cessation Interventions at the Point of Diagnosis of Non-Small Cell Lung Cancer.
Value Health
; 26(8): 1192-1200, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37059391
2.
Cost-effectiveness analysis of treatment of venous thromboembolism with rivaroxaban compared with combined low molecular weight heparin/vitamin K antagonist.
Thromb J
; 13: 20, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26074735
3.
Cost-effectiveness analysis of a low-dose contraceptive levonorgestrel intrauterine system in Sweden.
Acta Obstet Gynecol Scand
; 94(8): 884-90, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26015090
4.
The Cost of Unintended Pregnancies in Canada: Estimating Direct Cost, Role of Imperfect Adherence, and the Potential Impact of Increased Use of Long-Acting Reversible Contraceptives.
J Obstet Gynaecol Can
; 37(12): 1086-97, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26637081
5.
The burden of moderate/severe premenstrual syndrome and premenstrual dysphoric disorder in a cohort of Latin American women.
Value Health
; 14(5 Suppl 1): S93-5, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21839909
6.
The cost of inpatient burn management in Nepal.
Burns
; 47(7): 1675-1682, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33947601
7.
A Structured Review to Assess the Current Status of Cost-Based Burns Research in Nepal.
J Burn Care Res
; 42(1): 93-97, 2021 02 03.
Artigo
Inglês
| MEDLINE | ID: mdl-32780811
8.
The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France.
Diabetes Ther
; 9(1): 13-25, 2018 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-29134607
9.
The cost-effectiveness of dulaglutide versus liraglutide for the treatment of type 2 diabetes mellitus in Spain in patients with BMI ≥30 kg/m2.
J Med Econ
; 20(5): 443-452, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-28008768
10.
The cost-effectiveness of 5-FU-SA in the treatment of actinic keratoses of the face and scalp in the UK secondary care setting.
J Med Econ
; 20(3): 221-227, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-27715356
11.
The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease.
J Med Econ
; 20(11): 1207-1215, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28895769
12.
Achieving cost-neutrality with long-acting reversible contraceptive methods.
Contraception
; 91(1): 49-56, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25282161
13.
Direct costs of unintended pregnancy in the Russian federation.
Appl Health Econ Health Policy
; 13(1): 61-8, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25269779
14.
Cost of unintended pregnancy in Norway: a role for long-acting reversible contraception.
J Fam Plann Reprod Health Care
; 41(2): 109-15, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25537792
15.
A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden.
J Med Econ
; 16(6): 756-62, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23556422
16.
The economic burden of advanced Parkinson's disease: an analysis of a UK patient dataset.
J Med Econ
; 14(1): 130-9, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21235405
17.
A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson's disease in the UK.
J Med Econ
; 14(5): 584-93, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21728911